Concept and viability of androgen annihilation for advanced prostate cancer

E-ISSN： 1097-0142|120|17|2628-2637

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.17, 2014-09, pp. : 2628-2637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 290-302

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A Golijanin Dragan J Miyamoto Hiroshi Messing Edward M

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite

Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer

By Koutsilieris Michael Mitsiades Constantine S

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 6, 2001-06 ,pp. : 1099-1115

Informa Healthcare

Access to resources Recommend Favorite

Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor-directed therapies

By Kim Won Ryan Charles J.

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 361-371

Blackwell Publishing

Access to resources Recommend Favorite

Histrelin: In Advanced Prostate Cancer

By Deeks Emma D.

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 623-630

Adis International

Access to resources Recommend Favorite